Similar articles

• [The future of molecular markers in cancer: towards a tailored treatment].

  Gascón P. Gascón P. Med Clin (Barc). 2009 Apr 18;132(14):549-50. doi: 10.1016/j.medcli.2008.12.019. Epub 2009 Apr 14. Med Clin (Barc). 2009. PMID: 19368936 Spanish. No abstract available.
• Biomarkers and subtypes of cancer.

  Starmans MH, Boutros PC. Starmans MH, et al. Aging (Albany NY). 2015 May;7(5):280-1. doi: 10.18632/aging.100741. Aging (Albany NY). 2015. PMID: 26021974 Free PMC article. No abstract available.
• Serum tumor markers: diagnostic or para-diagnostic.

  Mehdi I. Mehdi I. J Pak Med Assoc. 1998 May;48(5):118-20. J Pak Med Assoc. 1998. PMID: 9813969 No abstract available.
• [Uses of biological markers in the research and diagnosis of neoplasms].

  Yuan M. Yuan M. Zhonghua Bing Li Xue Za Zhi. 1993 Oct;22(5):307-9. Zhonghua Bing Li Xue Za Zhi. 1993. PMID: 8168200 Review. Chinese. No abstract available.
• Tumor immunology.

  Kagan JM, Fahey JL. Kagan JM, et al. JAMA. 1987 Nov 27;258(20):2988-92. JAMA. 1987. PMID: 2444724 Review. No abstract available.